Pharsight

1. Atacand patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5196444 (Pediatric)	ANI PHARMS	1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof	Dec, 2012 (11 years ago)
US5534534	ANI PHARMS	Pharmaceutical compositions for oral use and method of preparing them	Jul, 2013 (10 years ago)
US5534534 (Pediatric)	ANI PHARMS	Pharmaceutical compositions for oral use and method of preparing them	Jan, 2014 (10 years ago)

Market Authorisation Date: 04 June, 1998

Treatment: NA

Dosage: TABLET;ORAL

Strength	Submission Date	ANDA(s) Filed	First applicant approval	Last patent expiry	180 day status
4 mg, 8 mg, 16 mg and 32 mg	22 Dec, 2006	1	03 May, 2013	09 Jan, 2014	Eligible

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5196444 (Pediatric)	ANI PHARMS	1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof	Dec, 2012 (11 years ago)
US5534534	ANI PHARMS	Pharmaceutical compositions for oral use and method of preparing them	Jul, 2013 (10 years ago)
US5534534 (Pediatric)	ANI PHARMS	Pharmaceutical compositions for oral use and method of preparing them	Jan, 2014 (10 years ago)
US5958961	ANI PHARMS	Pharmaceutical composition for angiotensin II-mediated diseases	Jun, 2014 (9 years ago)
US5721263	ANI PHARMS	Pharmaceutical composition for angiotensin II-mediated diseases	Feb, 2015 (9 years ago)

Market Authorisation Date: 05 September, 2000

Treatment: Treatment of hypertension

Dosage: TABLET;ORAL

Strength	Submission Date	ANDA(s) Filed	First applicant approval	Last patent expiry	180 day status
16 mg/12.5 mg and 32 mg/12.5 mg	25 Jun, 2008	1	04 Dec, 2012	24 Feb, 2015	Extinguished
32 mg/25 mg	06 Mar, 2009	1	04 Dec, 2012	24 Feb, 2015	Eligible

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry	Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6500454	ANI PHARMS	Timed, sustained release systems for propranolol	Oct, 2021 (2 years ago)

Market Authorisation Date: 12 March, 2003

Treatment: NA

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

Strength	Dosage	Availability
80MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription
120MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription

Patent	Proceeding Filing Date	Status	Respondent	Petitioner

US9770406	September, 2015	Decision	Yunik Chang et al

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5968973	ANI PHARMS	Method for treating hyperplasia	Apr, 2017 (7 years ago)
US5795911	ANI PHARMS	Composition for treating Condyloma acuminata	Oct, 2020 (3 years ago)
US10434059	ANI PHARMS	Medicament for the treatment of viral skin and tumour diseases	Nov, 2022 (1 year, 5 months ago)
US9770406	ANI PHARMS	Medicament for the treatment of viral skin and tumour diseases	Jul, 2025 (1 year, 2 months from now)
US7858662	ANI PHARMS	Medicament for the treatment of viral skin and tumour diseases	Oct, 2026 (2 years from now)

Market Authorisation Date: 31 October, 2006

Treatment: Treatment of genital warts

Dosage: OINTMENT;TOPICAL